FDA Approved: HEPARIN SODIUM — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Meitheal Pharmaceuticals Inc.'s Heparin Sodium as an Original Application (ANDA 211007), making a generic injectable anticoagulant available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Myocardial Infarction
• Pulmonary Embolism
• Stroke
• Venous Thromboembolism

Drugs mentioned

• HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

ORIG AP for HEPARIN SODIUM (HEPARIN SODIUM)